Skip to main content
. 2018 Feb 11;2018(2):CD001487. doi: 10.1002/14651858.CD001487.pub3

NCT00205790.

Trial name or title GORE‐TEX PROPATEN Vascular Graft Study
Methods Single‐blind randomised controlled trial
Participants 21 years and older, peripheral vascular disease requiring above‐knee femoro‐popliteal bypass
Interventions GORE‐TEX PROPATEN vascular grafts versus thin walled GORE‐TEX Stretch vascular grafts
Outcomes Primary outcome measures: primary patency at 12 months; major device complication rates at 12 months
 Secondary outcome measures: technical failures; secondary patency
Starting date February 2003. Trial completed recruitment in 2007 but still has not published results
Contact information Enrico Ascher, MD Maimonides Hospital, Brooklyn NY
Notes Sponsored by WL Gore & Associates
ClinicalTrials.gov identifier: NCT00205790

PTFE: polytetrafluoroethylene